Cancer Diagnostics Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Cancer Diagnostics Market to 2025 - Global Analysis and Forecasts By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC) and Others), Application (Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer and Other Cancers) and Geography

Report Code: TIPMD00002290 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. The cancer diagnostics include sophisticated diagnostic technology to evaluate tumors and develop a personalized treatment plan. Some types of cancer, such as lymphomas, can be hard to classify, even for an expert. The method for the treatment and diagnosis of the disease depends on the patient and the severity of the cancer. The most common diagnostic methods include endoscopy, biopsy, diagnostic imaging and blood tests.

The cancer diagnostics market of is expected to grow with a significant rate in the forecast years, owing to driving factors such as, increasing prevalence of cancer, technological improvements, public-private partnerships to improve the infrastructure of diagnostic imaging centers and FDA support for biomarker development. The companion diagnostics, personalized medicine are likely to offer more opportunities in the cancer diagnostics market.

The “Global Cancer Diagnostics Market Analysis To 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global cancer diagnostics market with detailed market segmentation by technology, application and geography. The global cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the cancer diagnostics market.

The global cancer diagnostics market is segmented on the basis of technology and application. The technology segment includes fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC) and others. The application segment is classified as breast cancer, lung cancer, melanoma, colorectal cancer and other cancers.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer diagnostics market based on technology, application and geography. It also provides market size and forecast till 2025 for overall cancer diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the cancer diagnostics market in the coming years, owing to factors such as, various market players operate in this region. The European region is expected to hold the second largest market for the cancer diagnostics. Asia Pacific is anticipated to be the fastest growing market as the due to the growing number of the cancer cases in the countries.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key cancer diagnostics market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Merck KGaA, GenScript, Cell Signaling Technology, Inc., PerkinElmer Inc., Cancer Diagnostics, Inc. and MultiplexDx International.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. CANCER DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Cancer Diagnostics Market – By Technology
3.2.2. Cancer Diagnostics Market – By Application
3.2.3. Cancer Diagnostics Market – By Region
3.2.3.1. By Country

4. CANCER DIAGNOSTICS MARKET – KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. IMPACT ANALYSIS

5. CANCER DIAGNOSTICS MARKET – GLOBAL ANALYSIS
5.1. GLOBAL CANCER DIAGNOSTICS MARKET OVERVIEW
5.2. GLOBAL CANCER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
?

6. CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET
6.3.1. Overview
6.3.2. Fluorescent In Situ Hybridization (FISH) Market Revenue Forecasts and Analysis (US$ Mn)
6.4. COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MARKET
6.4.1. Overview
6.4.2. Comparative Genomic Hybridization (CGH) Market Revenue Forecasts and Analysis (US$ Mn)
6.5. IMMUNOHISTOCHEMICAL (IHC) MARKET
6.5.1. Overview
6.5.2. Immunohistochemical (IHC) Market Revenue Forecasts and Analysis (US$ Mn)
6.6. OTHERS MARKET
6.6.1. Overview
6.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

7. CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. BREAST CANCER MARKET
7.3.1. Overview
7.3.2. Breast Cancer Market Revenue Forecasts and Analysis (US$ Mn)
7.4. LUNG CANCER MARKET
7.4.1. Overview
7.4.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MELANOMA MARKET
7.5.1. Overview
7.5.2. Melanoma Market Revenue Forecasts and Analysis (US$ Mn)
?
7.6. COLORECTAL CANCER MARKET
7.6.1. Overview
7.6.2. Colorectal Cancer Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHER CANCERS MARKET
7.7.1. Overview
7.7.2. Other Cancers Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
8.1. NORTH AMERICA CANCER DIAGNOSTICS MARKET OVERVIEW
8.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY TECHNOLOGY (US$ MN)
8.4. NORTH AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
8.5. NORTH AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.6.2. US Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.7.2. Canada Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
8.8.2. Mexico Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
?
9. EUROPE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
9.1. EUROPE CANCER DIAGNOSTICS MARKET OVERVIEW
9.2. EUROPE CANCER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY TECHNOLOGY (US$ MN)
9.4. EUROPE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
9.5. EUROPE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.6.2. France Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.2. Germany Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.2. UK Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

10. ASIA PACIFIC CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
10.1. ASIA PACIFIC CANCER DIAGNOSTICS MARKET OVERVIEW
10.2. ASIA PACIFIC CANCER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY TECHNOLOGY (US$ MN)
10.4. ASIA PACIFIC CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
?
10.6. CHINA MARKET OVERVIEW
10.6.1. China Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.6.2. China Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.2. India Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.2. Japan Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY TECHNOLOGY (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.2. South Africa Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Cancer diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.2. Saudi Arabia Cancer diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.2. UAE Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. SOUTH AND CENTRAL AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA CANCER DIAGNOSTICS MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA CANCER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY TECHNOLOGY (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Cancer Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.2. Brazil Cancer Diagnostics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. F. HOFFMANN-LA ROCHE AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
?
13.3. AGILENT TECHNOLOGIES, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ILLUMINA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK KGAA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GENSCRIPT
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
?
13.7. CELL SIGNALING TECHNOLOGY, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PERKINELMER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CANCER DIAGNOSTICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MULTIPLEXDX INTERNATIONAL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
?
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies

1. F. Hoffmann-La Roche AG
2. Thermo Fisher Scientific, Inc.
3. Agilent Technologies, Inc.
4. Illumina, Inc.
5. Merck KGaA
6. GenScript
7. Cell Signaling Technology, Inc.
8. PerkinElmer Inc.
9. Cancer Diagnostics, Inc.
10. MultiplexDx International

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book